A multi-center real-life study on comparison between bismuth quadruple (BQ) (10 days) and clarithromycin (CLA) containing non-bismuth quadruple (CT) therapy (10 and 14 days) in the eradication of H. pylori infection in patients naive to treatment in a region with high CLA and dual resistance

Gravina A. G.; Zagari R. M.; Nardone G.; Federico A.; Dallio M.; Martorano M.; Mucherino C.; Romiti A.; Avallone L.; Granata L.; Colacino L.; Facchiano A.; Picascia D.; Sgambato D.; Miranda A.; Romano L.; Loguercio C.; Romano M.

首页> 外文期刊>Helicobacter >A multi-center real-life study on comparison between bismuth quadruple (BQ) (10 days) and clarithromycin (CLA) containing non-bismuth quadruple (CT) therapy (10 and 14 days) in the eradication of H. pylori infection in patients naive to treatment in a region with high CLA and dual resistance

【24h】

A multi-center real-life study on comparison between bismuth quadruple (BQ) (10 days) and clarithromycin (CLA) containing non-bismuth quadruple (CT) therapy (10 and 14 days) in the eradication of H. pylori infection in patients naive to treatment in a region with high CLA and dual resistance

机译：铋四肢（BQ）（10天）（10天）和克拉霉素（CLA）含有非铋四（CT）治疗（10和14天）的多中心现实研究，在患者中消除H. Pylori感染天真地治疗一个高CLA和双电阻的区域

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Helicobacter》 |2019年第1期|共1页
作者
Gravina A. G.; Zagari R. M.; Nardone G.; Federico A.; Dallio M.; Martorano M.; Mucherino C.; Romiti A.; Avallone L.; Granata L.; Colacino L.; Facchiano A.; Picascia D.; Sgambato D.; Miranda A.; Romano L.; Loguercio C.; Romano M.;
展开▼
作者单位

Univ Campania Luigi Vanvitelli Dept Precis Med Div Hepatogastroenterol Naples Italy;

Univ Bologna Dept Med &

Surg Sci Bologna Italy;

Univ Naples Federico II Div Gastroenterol Naples Italy;

Univ Campania Luigi Vanvitelli Dept Precis Med Div Hepatogastroenterol Naples Italy;

Univ Campania Luigi Vanvitelli Dept Precis Med Div Hepatogastroenterol Naples Italy;

Immacolata Hosp Gastroenterol &

Endoscopy Unit Sapri Italy;

S Anna S Sebastiano Hosp Gastroenterol &

Endoscopy Unit Caserta Italy;

Univ Bologna Dept Med &

Surg Sci Bologna Italy;

Univ Campania Luigi Vanvitelli Dept Precis Med Div Hepatogastroenterol Naples Italy;

Univ Campania Luigi Vanvitelli Dept Precis Med Div Hepatogastroenterol Naples Italy;

Univ Campania Luigi Vanvitelli Dept Precis Med Div Hepatogastroenterol Naples Italy;

Univ Campania Luigi Vanvitelli Dept Precis Med Div Hepatogastroenterol Naples Italy;

Univ Campania Luigi Vanvitelli Dept Precis Med Div Hepatogastroenterol Naples Italy;

Univ Campania Luigi Vanvitelli Dept Precis Med Div Hepatogastroenterol Naples Italy;

Univ Campania Luigi Vanvitelli Dept Precis Med Div Hepatogastroenterol Naples Italy;

Univ Naples Federico II Dept Clin Med &

Surg Surg Digest Endoscopy Naples Italy;

Univ Campania Luigi Vanvitelli Dept Precis Med Div Hepatogastroenterol Naples Italy;

Univ Campania Luigi Vanvitelli Dept Precis Med Div Hepatogastroenterol Naples Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类微生物学;
关键词

相似文献

外文文献

1. A multi-center real-life study on comparison between bismuth quadruple (BQ) (10 days) and clarithromycin (CLA) containing non-bismuth quadruple (CT) therapy (10 and 14 days) in the eradication of H. pylori infection in patients naive to treatment in a region with high CLA and dual resistance [J] . Gravina A. G., Zagari R. M., Nardone G., Helicobacter . 2019,第Suppla1期

机译：铋四肢（BQ）（10天）（10天）和克拉霉素（CLA）含有非铋四（CT）治疗（10和14天）的多中心现实研究，在患者中消除H. Pylori感染天真地治疗一个高CLA和双电阻的区域
2. 10-Day Versus 14-Day Quadruple Concomitant Nonbismuth Therapy for the Treatment ofHelicobacter pyloriInfection Results From a Randomized Prospective Study in a High Clarithromycin Resistance Country [J] . Journal of clinical gastroenterology . 2020,第6期

机译：10天与14天四人伴随的非球杆菌治疗幽门螺杆菌植物的治疗结果来自高分慢朗霉素抵抗国家的随机前瞻性研究
3. Effectiveness and safety of bismuth quadruple therapy (Pylera (R)) in combination with PPIs for the eradication of H. pylori infection in patients with dual clarithromycin and metronidazole resistance [J] . Fiorini G., Saracino I. M., Gatta L., Helicobacter . 2017,第S1期

机译：铋四重疗法（Pylera（R））与PPI结合用于消除双韵霉素和甲硝唑抗性的幽门螺杆菌感染的PPI的有效性和安全性
4. Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection [O] . Seong tae Lee, Dong Ho Lee, Ji Hyun Lim, 2019

机译：7天和14天含铋四联疗法和7天和14天莫西沙星为基础的三联疗法根除幽门螺杆菌感染的疗效
5. Eradication Rates for Esomeprazole and Lansoprazole-Based 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Anti-Helicobacter pylori Treatment in Real World Clinical Practice [O] . Kuo-Tung Hung, Shih-Cheng Yang, Cheng-Kun Wu, 2021

机译：EsomePrazole和兰辛唑的7天非铋伴有四线抗幽门螺杆菌治疗综合治疗的蒸汽唑唑和兰辛拉唑的7天非铋治疗

A multi-center real-life study on comparison between bismuth quadruple (BQ) (10 days) and clarithromycin (CLA) containing non-bismuth quadruple (CT) therapy (10 and 14 days) in the eradication of H. pylori infection in patients naive to treatment in a region with high CLA and dual resistance

著录项

相似文献

相关主题

期刊订阅